ITRM vs TDG · rev $390.0K vs P/E 41, rev $8.83B
Iterum Therapeutics PLC (ITRM) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. Revenue was up 11.2% from 2024-09-30 to 2025-09-30. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
ITRM currently screens at market cap $38.6M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the ITRM and TDG stock pages for the full models.
Not investment advice.